Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P11
Within normal range
vs 5Y Ago
-16.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -25.21% |
| 2024 | -41.66% |
| 2023 | 66.38% |
| 2022 | -23.42% |
| 2021 | 1.63% |
| 2020 | 1.54% |
| 2019 | 20.35% |
| 2018 | 243.86% |
| 2017 | 118.26% |
| 2016 | 0.00% |